Pancreatic Cancer

Pancreatic cancer breakthrough ‘can help sufferers survive an extra five years’

At the moment only 5% of patients live that long, and each year in the UK 8,800 people die of the disease


Pancreatic cancer survival rates have improved little since the early 1970s

A drug combination which can help pancreatic cancer sufferers survive for at least five years has been hailed as a breakthrough.

Currently, 5% of patients expect to live that long and a mere 1% are still alive 10 years after diagnosis. Survival rates have improved little since the early 1970s.

But a trial, published in the Lancet medical journal, found when chemo drugs gemcitabine and capecitabine were used together in post-op treatment, 29% lived at least five years – compared with 16% on gemcitabine alone.pancreatic cancer ag

The treatment protocol should now become the new standard of care for patients who have had surgery, experts said.

Next page

About the author


Leave a Comment